Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 5, 1997, Pages 683-692

  Cheng, Janet F ^a   Ott, Nancy L ^a   Peterson, Ellen A ^a   George, Terry J ^a   Hukee, Margaret J ^a   Gleich, Gerald J ^a   Leiferman, Kristin M ^a  

^a MAYO CLINIC   (United States)

Author keywords

atopic dermatitis; cytolytic degeneration; electron microspy; Eosinophi; granule; MBP; uropod

Indexed keywords

MAJOR BASIC PROTEIN;

ADOLESCENT; ADULT; ARTICLE; ATOPIC DERMATITIS; CYTOLYSIS; EOSINOPHILIA; EXOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; SCHOOL CHILD; SKIN BIOPSY;

EID: 0030952042     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70031-9     Document Type: Article

References (53)

1. Larsen FS, Holm NV, Henningsen K. Atopic dermatitis: a genetic-epidemiologic study in a population based twin study. J Am Acad Dermatol 1986;15:487-94.
2. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980;92:(suppl)44-7.
3. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol 1984;73:211-22.
4. Agosti JM, Sprenger JD, Lum LG, Witherspoon RP, Fisher LD, Storb R, et al. Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation. N Engl J Med 1988;319:1623-8.
5. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-37.
6. Leung DYM, editor. Atopic dermatitis: from pathogenesis to treatment. Austin (TX): RG Landes Company, 1996.
7. Gleich GJ. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease. J Allergy Clin Immunol 1982;70:160-9.
8. Leiferman KM, Fujisawa T, Gray BH, Gleich GJ. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 1990;62: 579-89.
9. Ott NL, Gleich GJ, Peterson EA, Fujisawa T, Sur S, Leiferman KM. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol 1994;94:120-8.
10. Gleich GJ, Adolphson CR, Leiferman KM. Eosinophils. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1992:663-700.
11. Mihm MC Jr, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976;67:305-12.
12. Soter NA. Morphology of atopic eczema. Allergy 1989;44(suppl 9):16-9.
13. Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med 1985;313:282-5.
14. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis: eosinophil granule proteins as markers of disease activity. Allergy 1993;48:1-5.
15. Uehara M, Izukura R, Sawai T. Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990;15:264-6.
16. Tsuda S, Kato K, Miyasato M, Sasai Y. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein. J Dermatol 1992;19:208-13.
17. Kagi MK, Joller-Jemelka H, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92.
18. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, et al. Recombinant Interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-97.
19. Walker C, Kagi MK, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen CA, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993;23:145-53.
20. Paganelli R, Fanales-Belasio E, Carmini D, Scala E, Meglio P, Businco L, et al. Serum eosinophil cationic protein in patients with atopic dermatitis. Int Arch Allergy Appl Immunol 1991;96:175-8.
21. Wuthrich B, Kagi MK, Joller-Jemelka H. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 1992;284:339-42.
22. Czech W, Krutmann J, Schopf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992;126:351-5.
23. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schopf E. High-dose UVAI therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225-30.
24. Juhlin L, Venge P. Eosinophilic cationic protein (ECP) in skin disorders. Acta Derm Venereol (Stock) 1992;71:495-501.
25. Stoughton RB. Percutaneous absorption of drugs. Annu Rev Pharmacol Toxicol 1989;29:55-69.
26. McDowell EM, Trump BF. Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med 1976;100: 405-14.
27. Spurr AR. A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastructure Res 1969;26:31-43.
28. Bendayan M, Zollinger M. Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique. J Histochem Cytochem 1983;31:101-9.
29. Wagner JM, Bartemes K, Vernof KK, Dunnette S, Offord KP, Checkel JL, et al. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 1993;14:671-81.
30. Peters MS, Schroeter AL, Kephart GM, Gleich GJ. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 1983;81:39-43.
31. Greenwood B. The motility of blood eosinophils on glass. Br J Dermatol 1969;81(suppl 3):36-7.
32. Galli SJ, Dvorak AM, Hammond E, Morgan E, Galli AS, Dvorak HF. Guinea pig basophil morphology in vitro. 1. Ultrastructure of uropod-bearing (motile) basophils and modulation of motile structures by serum and substrate effects. J Immunol 1981;126:1066-74.
33. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
34. Vercelli D, Jabara HH, Lee B, Woodland N, Geha RS, Leung DYM. Human recombinant interleukin-4 induces FceR2/CD23 on normal human monocytes. J Exp Med 1988;167:1406-16.
35. Gauchat J-F, Lebman DA, Coffman RL, Gascan H, deVries JE. Structure and expression of germline ε transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med 1990;172:463-73.
36. Silberstein DS, Austen KF, Owen WF Jr. Hemopoietins for eosinophils. Glycoprotein hormones that regulate the development of inflammation in eosinophilia-associated diseases. Hematol Oncol Clin North Am 1989;3:511-33.
37. Rothenberg ME, Peterson J, Stevens RL, Silberstein DS, McKenzie DT, Austen KF, et al. IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype use 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody dependent cytotoxicity. J Immunol 1989;143:2311-6.
38. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-42.
39. Minnicozzi M, Duran WN, Gleich GJ, Egan RW. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol 1994;153:2664-70.
40. Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol 1992;99:74-83.
41. Dvorak AM, Furitsu T, Letourneau L, Ishizaka T, Ackerman SJ. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Am J Pathol 1991; 138:69-82.
42. Dvorak AM, Ackerman SJ, Furitsu T, Estrella P, Letourneau L, Ishizaka T. Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation. Am J Pathol 1992;140:795-807.
43. Dvorak AM. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo. Cytotoxic potential in Crohn's disease. J Immunol 1980;125:460-2.
44. Dvorak AM, Ackerman SJ, Weller PF. Subcellular morphology and biochemistry of eosinophils. In: Harris JR, editor. Blood cell biochemistry, vol. 2. London: Plenum Publishing, 1991.
45. Dvorak AM, Onderdonk AB, McLeod RS, Monahan-Earley RA, Antonioli DA, Cullen J, et al. Ultrastructural identification of exocytosis of granules from human gut eosinophils in vivo. Int Arch Allergy Immunol 1993;102:33-45.
46. Gleich GJ, Schroeter AL, Marcoux JP, O'Connell EJ, Kohler PF. Episodic angioedema associated with eosinophilia. N Engl J Med 1984;310:1621-6.
47. Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest 1990;62:590-607.
48. Dvorak AM, Mihm MC, Osage JE, Kwan TH, Austen KF, Wintroub BU. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol 1982;78:91-101.
49. Hanker JS, Chandross RJ, Weatherly NE. Medusa cells: the morphology and cytochemistry of common ameboid variants of eosinophils. Histochem J 1980;12:701-15.
50. Hanker JS, Chandross RJ, Solic JJ, Weatherly NF, Laszlo J, Moore JO, et al. Medusa cells: cytostructure and cytochemistry of ameboid eosinophils with pseudopod-Iike processes. Histochem J 1981;13:905-19.
51. Berman EL, Carter HW, Ambrose WW, Hanker JS. Studies of eosinophil medusa cells by electron imaging modes. Scanning Electron Microsc 1983(pt 1):311-21.
52. del Pozo MA, Sánchez-Mateos P, Nieto M, Sánchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol 1995;131:495-508.
53. Dore M, Burns AR, Hughes BJ, Entman ML, Smith CW. Chemoattractant-induced changes in surface expression and redistribution of a functional ligand for P-selectin on neutrophils. Blood 1996;87:2029-37.